Compounded vs Brand-Name GLP-1: The Real Cost Comparison

The most effective weight loss medications available right now cost more per month than many people's car payments — without insurance. If you've looked into Ozempic, Wegovy, Mounjaro, or Zepbound and walked away stunned by the number, you're not wrong to be. This article breaks down exactly what brand-name GLP-1 medications cost, why they cost that much, and how compounded versions compare on price, active ingredient, and what you actually get.

What brand-name GLP-1 medications actually cost without insurance

Most insurance plans either exclude GLP-1 medications entirely for weight loss or require prior authorization that many patients never clear. That means the retail price is the real price for a significant portion of people seeking these medications.

Here is what brand-name GLP-1 medications cost at standard retail without insurance, based on manufacturer list prices and pharmacy pricing as of early 2026:

To be precise: Ozempic's manufacturer list price is approximately $1,027 per pen per month. Wegovy lists just under $1,350/mo. Mounjaro runs $1,060–$1,135/mo depending on dose. Zepbound sits at roughly $1,000/mo at standard retail.

Each manufacturer offers self-pay savings programs for uninsured patients. Novo Nordisk's current self-pay pricing for Ozempic runs $349–$499/mo depending on dose, with a limited introductory offer for new patients at certain doses. Eli Lilly's LillyDirect program has reduced Zepbound vial pricing to $299–$449/mo for patients who qualify. These programs narrow the gap — but they come with restrictions: dose eligibility windows, program terms that can change, and the reality that not every patient will qualify or want to navigate the enrollment process.

Even at reduced self-pay rates, these medications run several hundred dollars a month for an indefinite period. At $1,000/mo, a full year of Ozempic costs $12,000 out of pocket before any dose increases.

Why brand-name GLP-1 medications are so expensive

The price is not arbitrary. GLP-1 medications required years of clinical development, large-scale trials across multiple indications, and the manufacturing infrastructure to produce biologic drugs at scale. Novo Nordisk and Eli Lilly both invested billions developing and gaining approval for these compounds, and current pricing reflects the standard pharmaceutical model: recoup that investment through exclusivity while patents hold.

GLP-1 drugs are also biologics — complex molecules that are significantly more expensive to manufacture than small-molecule pills like statins or blood pressure medications. The supply chain, cold storage requirements, and precision manufacturing all factor into the end cost.

Finally, because these drugs remain on patent, there are no generic alternatives. Without competition, list prices stay high. That changes when patents expire and biosimilar versions enter the market — but for most active GLP-1 compounds, that is still years away.

What is compounded GLP-1 medication?

Compounded medications are prepared by licensed compounding pharmacies — facilities that formulate drugs to specification rather than dispensing pre-manufactured brand-name products. Compounded semaglutide and tirzepatide use the same active pharmaceutical ingredient class as brand-name versions. However, compounded products are not FDA-approved and have not been independently evaluated for equivalence, bioavailability, or consistency with brand-name formulations.

What differs is the regulatory status. Brand-name drugs like Ozempic and Wegovy go through the FDA's New Drug Application process and receive approval as finished drug products, with that specific manufacturer's formulation evaluated for safety and efficacy. Compounded versions are prepared under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act, which permits compounding under specific conditions — including when a drug is on the FDA's shortage list, as semaglutide has been. The pharmacy must be state-licensed; 503B outsourcing facilities are also registered with and inspected by the FDA. The compounding pharmacy takes responsibility for quality standards on each batch it produces.

For a deeper look at how compounded semaglutide is made and how it differs from the brand-name version in practice, see our full explainer on what compounded semaglutide is.

How much does compounded semaglutide and tirzepatide cost at PureForty?

PureForty offers compounded semaglutide and compounded tirzepatide through a straightforward online process: medical intake, clinician review, and direct-to-door shipping from an FDA-registered compounding pharmacy. Pricing is structured by treatment cycle length, with longer cycles offered at a lower monthly rate. There are no subscriptions and no hidden fees on medication, consultation, or shipping.

See the full pricing breakdown for current plan details. The table below summarizes monthly rates for both medications across all available cycle lengths.

Every plan includes a licensed provider consultation, the medication itself, and free shipping. There is no separate charge for the clinical review and no enrollment fee or subscription to cancel if your plan changes.

Cost comparison: compounded semaglutide vs Ozempic, Wegovy, Mounjaro, and Zepbound

The table below puts the numbers side by side. Brand-name prices reflect standard retail without insurance. Annual savings figures compare PureForty's six-month plan rate — the lowest available monthly price — against the brand-name retail list price.

These figures reflect standard retail pricing. If you are comparing against a manufacturer's self-pay program, the gap narrows. Even at Eli Lilly's lowest LillyDirect Zepbound pricing of $299/mo, compounded tirzepatide at PureForty's $199/mo six-month rate is still $100/mo less — $1,200 per year — without needing to enroll in or track a manufacturer savings program with its own eligibility conditions.

Is compounded GLP-1 medication as effective as the brand-name version?

The active pharmaceutical ingredient in compounded semaglutide is the same molecule — semaglutide — as in Ozempic and Wegovy. The same is true of compounded tirzepatide relative to Mounjaro and Zepbound. The mechanism of action does not change based on whether the drug was produced by a pharmaceutical company or formulated by a compounding pharmacy.

What compounded versions lack is the FDA's evaluation and approval of the finished drug product. The FDA approval process assesses the specific formulation as manufactured by the brand-name maker — its stability, sterility, bioavailability, and manufacturing controls. A compounding pharmacy is responsible for ensuring quality through its own internal protocols and the oversight of the state board of pharmacy, or for 503B outsourcing facilities, periodic FDA inspections.

No head-to-head clinical trials directly compare compounded GLP-1 formulations against their brand-name counterparts for efficacy. The assumption that the active ingredient behaves identically rests on chemistry, not a direct comparative clinical study. That is an honest limitation worth understanding before you decide. For patients in complex clinical situations — or those with conditions that make precise pharmacokinetics especially important — a licensed clinician may have a specific view on whether compounded or brand-name is the more appropriate choice.

What is included in PureForty's price

The monthly price at PureForty covers everything required to receive and use the medication. There are no line items to watch for, and no separate charges added at checkout.

• Provider consultation — a licensed clinician reviews your medical intake and, if appropriate, prescribes the medication. This is not a separate fee.
• Medication — compounded semaglutide or tirzepatide, formulated and dispensed by an FDA-registered compounding pharmacy.
• Free shipping — delivered directly to your door, refrigerated where required by the formulation.
• No subscription — you pay per treatment cycle. One month, three months, or six months. If your plan changes, you stop. There is no automatic renewal to cancel.
• FSA/HSA accepted — eligibility varies by plan — the cost may qualify under a flexible spending or health savings account. Verify eligibility with your FSA/HSA administrator.

Ongoing clinician access through your PureForty account is included. If you have questions about your dosing schedule, experience a side effect that needs attention, or want to discuss switching medications after a treatment cycle, that conversation is available without a separate appointment fee.

For the full clinical picture on how semaglutide and tirzepatide work, see the weight loss medication page.